Cook Medical to Explore Issues Affecting the Periphery at the 10th Annual Vascular InterVentional Advances (VIVA) Meeting

Cook’s breadth of presentations highlights company’s commitment to the evolving field of peripheral intervention

VIVA 2012

LAS VEGAS--()--Cook Medical will host multiple sessions on issues affecting the periphery at the 10th annual Vascular InterVentional Advances (VIVA) meeting in Las Vegas. Led by world-renowned physicians, Cook’s presentations will examine the current state of the stenting market, a global look at peripheral arterial disease (PAD) and new approaches in limb preservation.

WHEN         October 9 -12, 2012
 
WHERE

Cook Medical Pavilion
Booth #101, Premiere Suite #4
Wynn Las Vegas
3131 Las Vegas Blvd. South
Las Vegas, NV 89109

 
WHAT A glance at Cook’s scheduled sessions:
 

How Often Will We Use Drug-Eluting Stents – What Patients/Lesions Will Be the Most Likely to Benefit?
Featuring: Michael Dake, M.D., Stanford Hospital
Tuesday, October 9, 2012 at 8:19 a.m. PDT; General Session

 

Why Drug Eluting Technologies Will Be the Standard of Care in the SFA
Featuring: Michael Dake, M.D., Stanford Hospital; Mark Burket, M.D., University of Toledo Medical Center, Toledo, Ohio; and Andrew Holden, M.D., Auckland City Hospital, New Zealand
Tuesday, October 9, 2012 at 12:00 p.m. PDT; Cook Pavilion

 

Breakfast Symposium and Interactive Master Class: Tibiopedal Access and Amputation Prevention
Featuring: Craig Walker, M.D., Terrebone General Hospital, Houma, LA; George Adams, M.D., Rex Health, North Carolina; Jihad Mustapha, M.D., Metro Heart & Vascular Institute; and Marco Manzi, M.D., Abano Terme, Italy
Wednesday, October 10, 2012 at 7:00 a.m. PDT; Cook Pavilion

 

Update on 3-Year Zilver PTX Randomized Data
Featuring: Michael Dake, M.D., Stanford Hospital
Wednesday, October 10, 2012 at 1:20 p.m. PDT; General Session

 

Is There Clinical Benefit to Using Drug-Eluting Technologies Over POBA and Bare Metal
Stents?
Featuring: Dierk Scheinert, M.D., Leipzig. Germany
Thursday, October 11, 2012 at 8:26 a.m. PDT; General Session

 

How Will Drug Eluting Technologies Impact Your Practice Clinically and Economically?
Featuring: Gary Ansel, M.D., Riverside Methodist Hospital; Mark Burket, M.D., University of Toledo Medical Center, Toledo, Ohio; and Dierk Scheinert, M.D., Leipzig. Germany
Thursday, October 11, 2012 at 12:00 p.m. PDT; Cook Pavilion

 

About Vascular InterVentional Advances (VIVA)

Vascular InterVentional Advances, VIVA, is celebrating 10 years of defining excellence in professional education in the field of vascular intervention and medicine.

Over the past decade, VIVA has attracted a multispecialty audience and provided a broad and well-rounded educational experience for all participants involved in the care of patients with vascular disease. Attendees include those from vascular surgery, interventional cardiology, vascular medicine, interventional radiology, neuroradiology, neurosurgery, and cardiothoracic surgery.

About Cook Medical

A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide. For more information, visit www.cookmedical.com. Follow Cook Medical on Twitter and LinkedIn.

Contacts

Cook Medical
David McCarty, 812-339-2235, ext. 2387
Global Director, Public Relations
dave.mccarty@cookmedical.com
or
Racepoint Group
Jackie Hanley, 617-794-6939
jhanley@racepointgroup.com

Release Summary

Cook Medical will host multiple sessions on issues affecting the periphery at the tenth annual Vascular InterVentional Advances (VIVA) meeting in Las Vegas.

Sharing

Contacts

Cook Medical
David McCarty, 812-339-2235, ext. 2387
Global Director, Public Relations
dave.mccarty@cookmedical.com
or
Racepoint Group
Jackie Hanley, 617-794-6939
jhanley@racepointgroup.com